Goldstein D - Search Results

1

No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting.

Jacob F, Meier M, Caduff R, Goldstein D, Pochechueva T, Hacker N, Fink D, Heinzelmann-Schwarz V. Jacob F, et al. Among authors: goldstein d. Gynecol Oncol. 2011 Jun 1;121(3):487-91. doi: 10.1016/j.ygyno.2011.02.022. Epub 2011 Mar 21. Gynecol Oncol. 2011. PMID: 21420727 Free article.

2

Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies.

Pochechueva T, Jacob F, Goldstein DR, Huflejt ME, Chinarev A, Caduff R, Fink D, Hacker N, Bovin NV, Heinzelmann-Schwarz V. Pochechueva T, et al. Among authors: goldstein dr. Glycoconj J. 2011 Dec;28(8-9):507-17. doi: 10.1007/s10719-011-9349-y. Epub 2011 Sep 23. Glycoconj J. 2011. PMID: 21948103 Free PMC article.

3

Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs.

Jacob F, Goldstein DR, Fink D, Heinzelmann-Schwarz V. Jacob F, et al. Among authors: goldstein dr. Biomark Med. 2009 Dec;3(6):743-56. doi: 10.2217/bmm.09.48. Biomark Med. 2009. PMID: 20476844 Free article.

4

Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array.

Jacob F, Goldstein DR, Bovin NV, Pochechueva T, Spengler M, Caduff R, Fink D, Vuskovic MI, Huflejt ME, Heinzelmann-Schwarz V. Jacob F, et al. Among authors: goldstein dr. Int J Cancer. 2012 Jan 1;130(1):138-46. doi: 10.1002/ijc.26002. Epub 2011 Apr 25. Int J Cancer. 2012. PMID: 21351089 Free PMC article.

5

Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancer.

Buehler M, Tse B, Leboucq A, Jacob F, Caduff R, Fink D, Goldstein DR, Heinzelmann-Schwarz V. Buehler M, et al. Among authors: goldstein dr. Biomed Res Int. 2013;2013:238284. doi: 10.1155/2013/238284. Epub 2013 Jun 27. Biomed Res Int. 2013. PMID: 23878800 Free PMC article.

6

Identification of molecular apocrine breast tumours by microarray analysis.

Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D, Duss S, Nicoulaz AL, Brisken C, Fiche M, Delorenzi M, Iggo R. Farmer P, et al. Among authors: goldstein d. Oncogene. 2005 Jul 7;24(29):4660-71. doi: 10.1038/sj.onc.1208561. Oncogene. 2005. PMID: 15897907 Free article.

7

Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease.

Heiss JD, Ray-Chaudhury A, Kleiner DE, Ehrlich DJ, Scott G, Edwards NA, Goldstein DS, Hammoud DA, Hadaczek P, Van Laar VS, Graff SA, Herscovitch P, Lungu C, Hallett M, Lonser RR, Zaghloul KA, Bankiewicz KS. Heiss JD, et al. Among authors: goldstein ds. Mov Disord. 2024 May 8. doi: 10.1002/mds.29820. Online ahead of print. Mov Disord. 2024. PMID: 38718138

8

From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views.

Best MC, Butow P, Savard J, Newson AJ, Campbell R, Vatter S, Napier CE, Bartley N, Tucker K, Ballinger ML, Thomas DM; PiGeOn Project. Best MC, et al. Oncologist. 2024 May 7:oyae074. doi: 10.1093/oncolo/oyae074. Online ahead of print. Oncologist. 2024. PMID: 38713191

9

Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model.

Watson E EE, Hueniken K, Lee J, Huang SH, El Maghrabi A, Xu W, Moreno AC, Tsai CJ, Hahn E, McPartlin AJ, Yao CMKL, Goldstein DP, De Almeida JR, Waldon JN, Fuller CD, Hope AJ, Ruggiero SL, Glogauer M, Hosni AA. Watson E EE, et al. Among authors: goldstein dp. J Clin Oncol. 2024 May 1:JCO2301951. doi: 10.1200/JCO.23.01951. Online ahead of print. J Clin Oncol. 2024. PMID: 38691822

10

Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.

Yeung N, Li T, Lin HM, Timmins HC, Goldstein D, Harrison M, Friedlander M, Mahon KL, Giles C, Meikle PJ, Park SB, Horvath LG. Yeung N, et al. Among authors: goldstein d. JCO Precis Oncol. 2024 Apr;8:e2300690. doi: 10.1200/PO.23.00690. JCO Precis Oncol. 2024. PMID: 38691814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,063 results

Search Page